UGT2B17 expression fold change in studies comparing IGHV mutated and unmutated CLL patient samples
| Study . | Affymetrix Chip . | N . | CD19-sorted . | Probe set ID . | UGT2B17 fold change . | P . |
|---|---|---|---|---|---|---|
| Shehata et al30 | U133A | 19 | yes | 207245_at | 8.2 | .028 |
| Bilban et al9 | U133A | 20 | no | 207245_at | 3.4 | .023 |
| Vasconcelos et al32 | U133A | 18 | yes | 207245_at | 3.9 | .031 |
| Haslinger et al33 | U95A | 100 | no | 33068_f_at | 1.9 | < .001 |
| Study . | Affymetrix Chip . | N . | CD19-sorted . | Probe set ID . | UGT2B17 fold change . | P . |
|---|---|---|---|---|---|---|
| Shehata et al30 | U133A | 19 | yes | 207245_at | 8.2 | .028 |
| Bilban et al9 | U133A | 20 | no | 207245_at | 3.4 | .023 |
| Vasconcelos et al32 | U133A | 18 | yes | 207245_at | 3.9 | .031 |
| Haslinger et al33 | U95A | 100 | no | 33068_f_at | 1.9 | < .001 |